Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ocular blood flow and prostaglandin E1]

M Yuguchi1, K Tamai

  • 1Department of Ophthalmology, Nagoya City University Medical School, Japan.

Nippon Ganka Gakkai Zasshi
|March 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extragenital lichen sclerosus successfully treated by topical maxacalcitol/betamethasone butyrate propionate.

Clinical and experimental dermatology·2020
Same author

Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility.

The British journal of dermatology·2020
Same author

Bone marrow transplant with post-transplant cyclophosphamide for recessive dystrophic epidermolysis bullosa expands the related donor pool and permits tolerance of nonhaematopoietic cellular grafts.

The British journal of dermatology·2019
Same author

ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1.

Cancer biology & therapy·2018
Same author

The incidence of nerve root injury by high-speed drill can be reduced by chilled saline irrigation in a rabbit model.

The bone & joint journal·2017
Same author

Successful treatment of nonunion with teriparatide after failed ankle arthrodesis for Charcot arthropathy.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2013

Prostaglandin E1 lowered rabbit blood pressure by 20-30% without affecting ocular blood flow. This suggests prostaglandin E1 could be a safe hypotensive agent for ophthalmic surgery.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Physiology

Context:

  • Systemic blood pressure regulation is crucial for maintaining ocular perfusion.
  • Prostaglandin E1 is known for its vasodilatory effects.
  • Understanding the impact of systemic agents on ocular hemodynamics is vital for surgical safety.

Purpose:

  • To investigate the effect of systemically administered prostaglandin E1 on ocular blood flow in rabbits.
  • To assess potential changes in ciliary body and choroidal blood flow following prostaglandin E1 administration.
  • To evaluate the safety of prostaglandin E1 as a hypotensive agent in the context of ophthalmic surgery.

Summary:

  • Intravenous prostaglandin E1 administration in rabbits resulted in a 20-30% decrease in systemic blood pressure.

Related Experiment Videos

  • Ocular blood flow, measured in the ciliary body and choroid using the hydrogen gas clearance method, showed no significant alterations.
  • Arterial blood gases, pupil size, and ocular tension remained largely unchanged, with only a slight, transient decrease in ocular tension.

    • Impact:

    • Prostaglandin E1 demonstrates potential utility as a hypotensive drug during ophthalmic procedures.
    • The lack of significant changes in ocular blood flow despite reduced systemic blood pressure supports its safety profile for eye surgery.
    • Further research may validate prostaglandin E1's role in managing intraoperative blood pressure in ophthalmology.